Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
NeuroMed Devices, Inc. is a medical technology company founded by Dr. Leon M. Silverstone that specialized in the development of non-invasive neuromodulation systems. The company's flagship products, ViraCalm™ and OraCalm™, were designed to deliver electrical stimulation to the peripheral nervous system for the management of chronic and acute pain. While the devices received FDA 510(k) clearance for pain relief, the company faced significant regulatory scrutiny for promoting them as treatments for herpes simplex virus (HSV) infections without clinical evidence. This led to a formal warning letter from the FDA and the eventual cessation of the company's commercial activities.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on NeuroMed Devices.